D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 92 Citations 31,970 573 World Ranking 6999 National Ranking 3780

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

Ahmet Dogan mainly focuses on Lymphoma, Pathology, Cancer research, MALT lymphoma and Internal medicine. Ahmet Dogan is involved in the study of Lymphoma that focuses on Follicular lymphoma in particular. His Pathology study combines topics in areas such as Immunophenotyping and Angioimmunoblastic T-cell lymphoma.

The study incorporates disciplines such as International Prognostic Index, Diffuse large B-cell lymphoma, Cell growth, Large-cell lymphoma and Syk in addition to Cancer research. His biological study spans a wide range of topics, including BCL10, Molecular biology and Mantle zone. His Internal medicine research focuses on subjects like Gastroenterology, which are linked to Refractory, Disease, Surgery, Allogeneic transplantation and Survival rate.

His most cited work include:

  • Immunoproliferative small-intestinal disease. An immunohistochemical study. (1894 citations)
  • The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website (916 citations)
  • Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing (726 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Pathology, Lymphoma, Internal medicine, Cancer research and Oncology. His research brings together the fields of Immunoglobulin light chain and Pathology. His Lymphoma study contributes to a more complete understanding of Immunology.

His Cancer research research includes themes of Gene expression profiling and Chromosomal translocation. His Oncology study combines topics from a wide range of disciplines, such as Single-nucleotide polymorphism and Bioinformatics. He usually deals with Amyloidosis and limits it to topics linked to Amyloid and Transthyretin.

He most often published in these fields:

  • Pathology (38.86%)
  • Lymphoma (36.54%)
  • Internal medicine (28.16%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (28.16%)
  • Cancer research (20.68%)
  • Oncology (16.04%)

In recent papers he was focusing on the following fields of study:

Ahmet Dogan mainly investigates Internal medicine, Cancer research, Oncology, Lymphoma and Multiple myeloma. His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Rituximab. Ahmet Dogan interconnects Mutation, Cancer cell, Somatic cell and Monoclonal in the investigation of issues within Cancer research.

His Oncology research focuses on Lenalidomide and how it connects with Phases of clinical research. His Lymphoma study is related to the wider topic of Pathology. His study in the field of Mucosa-associated lymphoid tissue also crosses realms of Extramural.

Between 2018 and 2021, his most popular works were:

  • Efficacy of MEK inhibition in patients with histiocytic neoplasms (75 citations)
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. (35 citations)
  • Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms. (31 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Ahmet Dogan spends much of his time researching Internal medicine, Lymphoma, Cancer research, Oncology and Multiple myeloma. In Internal medicine, Ahmet Dogan works on issues like Gastroenterology, which are connected to Autologous stem-cell transplantation. His Lymphoma research is multidisciplinary, incorporating elements of Retrospective cohort study and Cohort.

His studies deal with areas such as Mutation, Histiocytoses, MAPK/ERK pathway and Somatic cell as well as Cancer research. His research in Oncology intersects with topics in Patient population, Venetoclax, Obinutuzumab, Chronic lymphocytic leukemia and Relapsed refractory. His work deals with themes such as Immunoglobulin light chain, Computational biology and Gene, which intersect with Multiple myeloma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Immunoproliferative small-intestinal disease. An immunohistochemical study.

Peter G. Isaacson;Ahmet Dogan;Stephen K. Price;Jo Spencer.
The American Journal of Surgical Pathology (1989)

3027 Citations

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

S Bamford;E Dawson;S Forbes;J Clements.
British Journal of Cancer (2004)

1221 Citations

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Jens G. Lohr;Petar Stojanov;Petar Stojanov;Michael S. Lawrence;Daniel Auclair.
Proceedings of the National Academy of Sciences of the United States of America (2012)

1014 Citations

Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

Julie A. Vrana;Jeffrey D. Gamez;Benjamin J. Madden;Jason D. Theis.
Blood (2009)

903 Citations

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

Hongxiang Liu;Agnes Ruskon-Fourmestraux;Anne Lavergne-Slove;Hongtao Ye.
The Lancet (2001)

517 Citations

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

Hongxiang Liu;Hongtao Ye;Agnes RuskoneFourmestraux;Daphne De Jong.
Gastroenterology (2002)

500 Citations

CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.

Ahmet Dogan;Eniko Bagdi;Philippa Munson;Peter G. Isaacson.
The American Journal of Surgical Pathology (2000)

418 Citations

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Edgardo R. Parrilla Castellar;Elaine S. Jaffe;Jonathan W. Said;Steven H. Swerdlow.
Blood (2014)

412 Citations

Angioimmunoblastic T‐cell lymphoma

Ahmet Dogan;Ayoma D. Attygalle;Chara Kyriakou.
British Journal of Haematology (2003)

393 Citations

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma

Hongtao Ye;Hongxiang Liu;Ayoma Attygalle;Andrew C. Wotherspoon.
Blood (2003)

387 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ahmet Dogan

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 93

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 88

Randy D. Gascoyne

Randy D. Gascoyne

BC Cancer Agency

Publications: 88

Giampaolo Merlini

Giampaolo Merlini

University of Pavia

Publications: 85

Elaine S. Jaffe

Elaine S. Jaffe

National Institutes of Health

Publications: 81

Stefano Pileri

Stefano Pileri

European Institute of Oncology

Publications: 75

Elias Campo

Elias Campo

University of Barcelona

Publications: 73

Sanjeev Sethi

Sanjeev Sethi

Mayo Clinic

Publications: 73

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 70

Miguel A. Piris

Miguel A. Piris

Instituto de Salud Carlos III

Publications: 68

James R. Cerhan

James R. Cerhan

Mayo Clinic

Publications: 63

Francesco Bertoni

Francesco Bertoni

Institute of Oncology Research

Publications: 61

Nelson Leung

Nelson Leung

Mayo Clinic

Publications: 61

Andreas Rosenwald

Andreas Rosenwald

University of Würzburg

Publications: 60

Reiner Siebert

Reiner Siebert

University of Ulm

Publications: 59

Emanuele Zucca

Emanuele Zucca

Universita della Svizzera Italiana

Publications: 58

Trending Scientists

Marcos André Gonçalves

Marcos André Gonçalves

Universidade Federal de Minas Gerais

Roland W. Lewis

Roland W. Lewis

Swansea University

Alexander M. Kirillov

Alexander M. Kirillov

Instituto Superior Técnico

Signorino Galvagno

Signorino Galvagno

University of Messina

Seigo Ito

Seigo Ito

University of Hyogo

Mario Albrecht

Mario Albrecht

Max Planck Society

Richard Reinhardt

Richard Reinhardt

Max Planck Society

Joseph Travis

Joseph Travis

Florida State University

Renato Fani

Renato Fani

University of Florence

Christoffer Boström

Christoffer Boström

Åbo Akademi University

Sally E. Thompson

Sally E. Thompson

University of Western Australia

Catherine Haslam

Catherine Haslam

University of Queensland

William H. Turnley

William H. Turnley

Kansas State University

Patrick C. Friman

Patrick C. Friman

Boys Town

Paul Chatterton

Paul Chatterton

University of Leeds

Something went wrong. Please try again later.